相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study
Christopher B. Nahm et al.
EJSO (2019)
Mesothelin expression has prognostic value in stage / colorectal cancer
Takehiro Shiraishi et al.
VIRCHOWS ARCHIV (2019)
The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
Tyvette S. Hilliard
CANCERS (2018)
Mesothelin promotes epithelial-tomesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells
Xiaoqing He et al.
MOLECULAR CANCER (2017)
Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas
Morikazu Miyamoto et al.
ONCOLOGY (2017)
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Aurore Morello et al.
CANCER DISCOVERY (2016)
Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms
Takahiro Einama et al.
ONCOLOGY LETTERS (2015)
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis
Anish Thomas et al.
ONCOTARGET (2015)
Mesothelin expression is associated with poor outcomes in breast cancer
Yun R. Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma
Stefan S. Kachala et al.
CLINICAL CANCER RESEARCH (2014)
C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma
Futoshi Kawamata et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Recent changes in endometrial cancer trends among menopausal-age US women
Paige Wartko et al.
CANCER EPIDEMIOLOGY (2013)
Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer
T. Einama et al.
BRITISH JOURNAL OF CANCER (2012)
Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon
Mirte M. Streppel et al.
HUMAN PATHOLOGY (2012)
Contemporary management of endometrial cancer
Jason D. Wright et al.
LANCET (2012)
Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression
Uddalak Bharadwaj et al.
MOLECULAR CANCER (2011)
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma
Takahiro Einama et al.
PANCREAS (2011)
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
Amanda Nickles Fader et al.
GYNECOLOGIC ONCOLOGY (2009)
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma
Louis A. Dainty et al.
GYNECOLOGIC ONCOLOGY (2007)
CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients - From The Danish MALOVA Ovarian Cancer Study
Estrid V. S. Hogdall et al.
GYNECOLOGIC ONCOLOGY (2007)
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors
Jennifer A. A. Gubbels et al.
MOLECULAR CANCER (2006)
Potential markers that complement expression of CA125 in epithelial ovarian cancer
DG Rosen et al.
GYNECOLOGIC ONCOLOGY (2005)
Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion
A Rump et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Application of mesothelin immunostaining in tumor diagnosis
NG Ordonez
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases
BM Slomovitz et al.
GYNECOLOGIC ONCOLOGY (2003)
Tissue and serum CA125 expression in endometrial cancer
S Ginath et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
The CA 125 gene: A newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure
TJ O'Brien et al.
TUMOR BIOLOGY (2002)
分享论文
